KUALA LUMPUR, March 15 — A low-sodium diet can make a significant difference in managing Chronic Kidney Disease (CKD), a long-term condition characterised by the gradual loss of kidney function over time. Consultant Nephrologist and Kidney Transplantation at Sunway Medical Centre, Bandar Sunway, Dr Rosnawati Yahya, said some diets, such as Dietary Approaches to Stop … Read more
NAPLES, March 7 — Minuscule pieces of plastic lodged in the fatty deposits that line human arteries may be linked with higher risks for heart disease, strokes, and death, Italian researchers reported on Wednesday. Among 304 patients who underwent procedures to clear a major artery in the neck, 58 per cent were found to have … Read more
IPOH, Feb 19 — Former Universiti Pendidikan Sultan Idris (UPSI) vice-chancellor, Prof Datuk Zakaria Kasa, 67, who was acquitted and discharged of abusing his power by the Court of Appeal in Putrajaya on Thursday, passed away yesterday due to heart disease. His third son, Mohd Fauzi, 34, said that his late father breathed his last … Read more
EXTON, PA, Feb. 16, 2024 (GLOBE NEWSWIRE) — Millions of people worldwide are affected by Parkinson’s disease (PD), prompting the need for effective disease-modifying therapies (DMTs) to target this degenerative condition. With gene therapies emerging as an exciting potential mechanism of action (MOA) for future treatment, their success depends on a future shift in the … Read more
— Eton Cares patient support program offers $0 co-pay to eligible, commercially insured patients* —— Current Nitisinone market is estimated to exceed $50 million annually —— Product is now available exclusively through Optime Care — DEER PARK, Ill., Feb. 02, 2024 (GLOBE NEWSWIRE) — Eton Pharmaceuticals (“Eton” or “the Company”) (Nasdaq: ETON), an innovative pharmaceutical … Read more
BOSTON, Jan 31 — A new treatment shows promise against the deadly neurodegenerative disease ALS, a study based on mice showed yesterday. Amyotrophic lateral sclerosis, sometimes called Lou Gehrig’s disease after the famous baseball player, devastates nerve cells in the brain and spinal cord. It affects about 30,000 Americans at any given time, causing progressive … Read more
ZURICH, Switzerland, Jan. 31, 2024 (GLOBE NEWSWIRE) — Neurimmune announced today that it regained global rights to aducanumab, a recombinant human antibody developed to deplete brain amyloid. Aducanumab was granted FDA accelerated approval for the treatment of Alzheimer’s disease. Neurimmune licensed its antibody aducanumab for the treatment and prevention of Alzheimer’s disease to Biogen in … Read more
Mont-Saint-Guibert, Belgium, January 31, 2024, 7.00 am CEST – BioSenic (Euronext Brussels and Paris: BIOS), the clinical-stage company specializing in serious autoimmune and inflammatory diseases and cell therapy, today announces that it will attend and support the upcoming GvHGvL Meeting on 13-15 March, 2024 at University Hospital Regensburg, a biannual conference to lead scientific exchange … Read more
Research demonstrated that activation of the inflammasome/ASC speck pathway has a vital role in synaptic degeneration in Alzheimer’s Disease (AD). ZyVersa is developing IC 100, a monoclonal antibody targeting inflammasome ASC specks to block initiation and perpetuation of damaging inflammation in the central nervous system and peripheral tissues. WESTON, Fla., Jan. 24, 2024 (GLOBE NEWSWIRE) … Read more
In the Phase III NETTER-2 trial, Lutathera plus octreotide LAR significantly extended median PFS to 22.8 months vs. 8.5 months with high-dose octreotide LAR in patients with newly diagnosed grade 2 and 3 advanced gastroenteropancreatic neuroendocrine tumors (GEP-NETs)1 NETTER-2 is the first and only positive Phase III trial for a radioligand therapy (RLT) in the … Read more
